Apellis Pharmaceuticals
Why Robinhood?
You can watch APLS and buy or sell other stocks, ETFs, and their options commission-free!About APLS
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE.
APLS Key Statistics
Stock Snapshot
With a market cap of 5.25B, Apellis Pharmaceuticals(APLS) trades at $41.03. The stock has a price-to-earnings ratio of 41.01.
Apellis Pharmaceuticals(APLS) stock opened on 2026-07-06 at —. The price climbed to — and dipped to —.
The Apellis Pharmaceuticals(APLS)'s current trading volume is 0, compared to an average daily volume of 8.56M.
In the last year, Apellis Pharmaceuticals(APLS) shares hit a 52-week high of $41.14 and a 52-week low of $16.61.
In the last year, Apellis Pharmaceuticals(APLS) shares hit a 52-week high of $41.14 and a 52-week low of $16.61.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.